Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a ‘cash-burning inferno’
November 15, 2022 at 16:44 PM EST
Twist Bioscience Corp. stock slid 20% Tuesday, after a damning short seller report compared the company to the failed blood-testing startup Theranos, calling it a "cash-burning inferno" and a "'synthetic biology' swindle."
